Total Voting Rights

RNS Number : 4383W

The MedicX Fund Limited

18 November 2010

 



For immediate release

18 November 2010

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Total voting rights

In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 17 November 2010 was 142,417,110 with each share holding one voting right.  No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

End

For further information please contact:

MedicX Group: Keith Maddin, Chairman Mike Adams, Chief Executive Officer Mark Osmond, Chief Financial Officer	[phone]
Collins Stewart Europe Limited: Andrew Zychowski/Lucy Lewis	[phone]
Buchanan Communications: Charles Ryland/Lisa Baderoon	[phone]
MedicX Fund: David Staples, Chairman	[phone]

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 35 people operating across the UK.  

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

END

 

 

TVRGGGQPGUPUGWR